Skip to content

303: From Freezer to Bedside: Controlling Cryopreservation Variability in Cell Therapy Manufacturing with Sean Werner - Part 1

November 10, 2026 · 22 min

Show notes

The integrity of individual cells is the cornerstone of breakthrough cell and gene therapies—but translating lab discoveries into clinical success demands mastering cryopreservation challenges rarely discussed in depth.

Sean Werner, Chief Technology Officer of Cell Processing at BioLife Solutions,a leading provider of bioproduction tools and services to the cell and gene therapy and broader biopharma markets, has dedicated his career to safeguarding cell viability from the lab bench through to clinical application.

Topics discussed:

  • Sean Werner's unconventional career progression and early experiences in regenerative medicine (03:22)
  • The critical role of cryopreservation in cell and gene therapy product quality (05:59)
  • Biophysics of freezing: ice nucleation, supercooling, and their impact on cell viability (07:32)
  • Hidden pitfalls in cryopreservation, including ice recrystallization and osmotic stress (07:43)
  • Real-world challenges during clinical handling and thawing of cell therapies (11:18)
  • Why the commonly used -1°C per minute freeze rate is not universally optimal (13:09)
  • Difficulties in tracing clinical problems back to early cryopreservation choices (13:54)
  • Importance of evaluating long-term cell function, not just post-thaw viability (15:08)
  • Regulatory expectations around freeze-thaw processes in therapy manufacturing (16:34)

Smart insight: Success in cell therapy and advanced biologics is inseparable from mastery of cryopreservation. By adopting an experimental and data-driven mindset—questioning assumptions, customizing protocols, and measuring what truly matters—scientists can better fulfill that original promise: that a single cell, carefully protected, can change the course of medicine for patients worldwide.

If this episode has you rethinking freeze-thaw, here’s where to go next. Start with the science behind cryopreservation, then compare two takes on cryoprotectants: DMSO-free formulations and antifreeze-inspired chemistry.

  • Episodes 241 - 242: DMSO in Cell Therapy: Why Viability Scores Hide the Real Toxicity with Steve Oh
  • Episodes 161 - 162: How to Achieve 85%+ Cell Recovery Without DMSO’s Toxic Side Effects with Jeffrey Allen
  • Episodes 65 - 66: Freezing and Thawing Cells: the Science Behind Cryopreservation with Mark Davison
  • Episodes 129 - 130: Revolutionizing Cell Therapy Manufacturing: Reducing Costs to Reach More Patients with Jason Foster

Connect with Sean Werner:
Website: www.biolifesolutions.com
LinkedIn: https://www.linkedin.com/in/sean-werner-54688326/

Support the show

All episodes of Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.